Skip to main content
SpringerLink
Log in
Book cover

Handbook of Clinical Laboratory Testing During Pregnancy pp 55–70Cite as

Markers of Fetal Lung Maturity

  • Chapter

Part of the book series: Current Clinical Pathology ((CCPATH))

Abstract

Fetal organ development occurs in the first trimester of pregnancy and major growth occurs in the second. In the third trimester, the fetal organs mature, although at differing rates. The production of adequate pulmonary surfactant is one of the last developments. This critical process, termed fetal lung maturity (FLM), can be accelerated or delayed by a number of fetal and maternal conditions.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American College of Obstetricians and Gynecologists, Committee on Educational Bulletins: Assessment of Fetal Lung Maturity. ACOG Educational Bulletin No. 230. Washington, DC: American College of Obstetricians and Gynecologists, 1996.

    Google Scholar 

  2. Hook GER, Gilmore LB, Tombropoulos EG, Fabro SE. Fetal lung lamellar bodies in human amniotic fluid. Am Rev Respir Dis 1978; 117: 541 - 550.

    PubMed  CAS  Google Scholar 

  3. Snyder JM, Mendelson CR, Johnston JM. The morphology of lung development in the human fetus. In: Nelson GH, ed. Pulmonary Development: Transition from Intrauterine to Extrauterine Life. New York: Marcel Dekker, 1985, pp. 19 - 46.

    Google Scholar 

  4. Oulton M, Martin TR, Faulkner GT, Stinson D, Johnson JP. Developmental study of a lamellar body fraction isolated from human amniotic fluid. Pediatr Res 1980; 14: 722 - 728.

    PubMed  CAS  Google Scholar 

  5. Ashwood ER. Clinical chemistry of pregnancy. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry, 3rd ed. Philadelphia: Saunders, 1999, pp. 1736 - 1775.

    Google Scholar 

  6. Moore TR. A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol 2002; 186: 641 - 650.

    PubMed  Google Scholar 

  7. Hawgood S, Clements JA. Pulmonary surfactant and its apoproteins. J Clin Invest 1990; 86: 1 - 6.

    PubMed  CAS  Google Scholar 

  8. Persson A, Chang D, Crouch E. Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein. J Biol Chem 1990; 26510: 5755 - 5760.

    Google Scholar 

  9. Cochrane CG, Revak SD. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 1991; 254: 566 - 568.

    PubMed  CAS  Google Scholar 

  10. Haagsman HP, Diemel RV. Surfactant-associated proteins: functions and structural variation. Comp Biochem Physiol A Mol Integr Physiol 2001; 129: 91 - 108.

    PubMed  CAS  Google Scholar 

  11. Nogee LM, Gamier G, Dietz HC, et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994; 3: 1860 - 1863.

    Google Scholar 

  12. Andersen C, Ramsay JA, Nogee LM, et al. Recurrent familial neonatal deaths: hereditary surfactant protein B deficiency. Am J Perinatol 2000; 17: 219 - 224.

    PubMed  CAS  Google Scholar 

  13. Nelson GH, McPherson JC Jr. Respiratory distress syndrome in various cultures and a possible role of diet. In: Nelson GH, ed. Pulmonary Development: Transition from Intrauterine to Extrauterine Life. New York: Marcel Dekker, 1985, pp. 159 - 178.

    Google Scholar 

  14. Farrell PM, Avery ME. Hyaline membrane disease. Am Rev Respir Dis 1975; 111: 657 - 688.

    PubMed  CAS  Google Scholar 

  15. Minino AM, Arias E, Kochanek KD, Murphy SL, Smith BL. Deaths: Final Data for 2000. National Vital Statistics Reports. Hyattsville, MD: National Center for Health Statistics, 2002;50(15).

    Google Scholar 

  16. American College of Obstetricians and Gynecologists, Committee on Obstetric Practice: Antenatal Corticosteroid Therapy for Fetal Maturation. ACOG Committee Opinion No. 147, December 1994. Washington, DC: American College of Obstetricians and Gynecologists, 1994.

    Google Scholar 

  17. Hundertmark S, Dill A, Ebert A, et al. Foetal lung maturation in l lbeta-hydroxysteroid dehydrogenase type 1 knockout mice. Horm Metab Res 2002; 34: 545 - 549.

    PubMed  CAS  Google Scholar 

  18. Hundertmark S, Dill A, Buhler H, et al. C. I lbetahydroxysteroid dehydrogenase type 1: a new regulator of fetal lung maturation. Horm Metab Res 2002; 34: 537 - 544.

    PubMed  CAS  Google Scholar 

  19. Hallman M, Merritt TA, Jarvenpaa AL, et al. Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J Pediatr 1985; 106: 963 - 969.

    PubMed  CAS  Google Scholar 

  20. College of American Pathologists: CAP Surveys, Lung Maturity Survey, Set LM-B. Northfield, IL: College of American Pathologists, 2002.

    Google Scholar 

  21. College of American Pathologists. Supplemental questions on lamellar body counts. Surveys 2000;LM-C:4-5.

    Google Scholar 

  22. Darling RE, Zlatnik FJ. Comparison of amniotic fluid optical density, L/S ratio and creatinine concentration in predicting fetal pulmonary maturity. J Reprod Med 1985; 30: 460 - 464.

    PubMed  CAS  Google Scholar 

  23. Almeida OD Jr, Kitay DZ. Amniotic fluid urea nitrogen in the prediction of respiratory distress syndrome. Am J Obstet Gynecol 1988; 159: 465 - 468.

    PubMed  Google Scholar 

  24. Wood GP. The evaluation of fetal lung maturity by amniotic fluid analysis. South Med J 1975; 68: 538 - 541.

    PubMed  CAS  Google Scholar 

  25. Menashe M, Finci Z, Milwidsky A, Mayer M. Amniotic fluid protease activity, protease inhibitory activity, and fetal lung maturity. Am J Perinatol 1987; 4: 68 - 71.

    PubMed  CAS  Google Scholar 

  26. Prakash KN, Ramakrishnan AG, Suresh S, Chow TW. An investigation into the feasibility of fetal lung maturity prediction using statistical textural features. Ultrason Imaging 2001; 23: 39 - 54.

    PubMed  CAS  Google Scholar 

  27. Lenke R, Ashwood E. Lung maturity testing. In: Quilligan EJ, Zuspan FP, eds. Current Therapy in Obstetrics and Gynecology. Philadelphia: Saunders, 2000, pp. 418 - 420.

    Google Scholar 

  28. Kaneko K, Shimizu H, Arakawa H, Ogawa Y. Pulmonary surfactant protein A in sera for assessing neonatal lung maturation. Early Hum Dev 2001; 62: 11 - 21.

    PubMed  CAS  Google Scholar 

  29. Pryhuber GS, Hull WM, Fink I, McMahan MJ, Whitsett JA. Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity. Pediatr Res 1991; 30: 597 - 605.

    PubMed  CAS  Google Scholar 

  30. Delgado JC, Greene MF, Winkelman JW, Tanasijevic MJ. Comparison of disaturated phosphatidylcholine and fetal lung maturity surfactant/albumin ratio in diabetic and nondiabetic pregnancies. Am J Clin Pathol 2000; 113: 233 - 239.

    PubMed  CAS  Google Scholar 

  31. Alvarez JG, Richardson DK, Ludmir J. Prediction of respiratory distress syndrome by the novel dipalmitoyl phosphatidylcholine test. Obstet Gynecol 1996; 87: 429 - 433.

    PubMed  CAS  Google Scholar 

  32. Dubin SB. Determination of lamellar body size, number density and concentration by differential light scattering from amniotic fluid: physical significance of A650. Clin Chem 1988; 34: 938 - 943.

    PubMed  CAS  Google Scholar 

  33. Sbarra AJ, et al. Correlation between amniotic fluid optical density and LS ratio. Obstet Gynecol 1976; 48: 613 - 615.

    PubMed  CAS  Google Scholar 

  34. Spellacy WN, Buhi WC, Cruz AC, Gelman SR, Kellner KR, Birk SA. Assessment of fetal lung maturity: a comparison of the lecithin/sphingomyelin ratio and the tests of optical density at 400 and 650 nm. Am J Obstet Gynecol 1979; 134: 528 - 531.

    PubMed  CAS  Google Scholar 

  35. Moawad AH, Ismail MA, River LP. Use of the drop volume of amniotic fluid in predicting fetal lung maturity: clinical experience. J Reprod Med 1991; 36: 425 - 428.

    PubMed  CAS  Google Scholar 

  36. Sing EJ. Capillary method for assessment of pulmonary maturity in utero with the use of amniotic fluid. Am J Obstet Gynecol 1980; 136: 228 - 229.

    PubMed  CAS  Google Scholar 

  37. Tiwary CM, Goldkrand JW. Assessment of fetal pulmonic maturity by measurement of the surface tension of amniotic fluid lipid extract. Obstet Gynecol 1976; 48: 191 - 194.

    PubMed  CAS  Google Scholar 

  38. Socol ML, Sing E, Depp OR. The tap test: a rapid indicator of fetal pulmonary maturity. Am J Obstet Gynecol 1984; 148: 445 - 450.

    PubMed  CAS  Google Scholar 

  39. Russell JC. A calibrated fluorescence polarization assay for assessment of fetal lung maturity. Clin Chem 1987; 33: 1177 - 1184.

    PubMed  CAS  Google Scholar 

  40. Tait JF, Franklin RW, Simpson JB, Ashwood ER. Improved fluorescence polarization assay for use in evaluating fetal lung maturity: I. Development of the assay procedure. Clin Chem 1986; 32: 248 - 254.

    PubMed  CAS  Google Scholar 

  41. Shinitzky M, Goldfisher A, Bruck A, et al. A new method for assessment of fetal lung maturity. Br J Obstet Gynaecol 1976; 83: 838 - 844.

    PubMed  CAS  Google Scholar 

  42. Ashwood ER, Palmer SE, Lenke RR. Rapid fetal lung maturity testing: commercial versus NBDphosphatidylcholine assay. Obstet Gynecol 1992; 81: 1048 - 1053.

    Google Scholar 

  43. Grenache DG, Parvin CA, Gronowski AM. Preanalytical factors that influence the Abbott TDx Fetal Lung Maturity II Assay. Clin Chem 2003; 49: 935 - 939.

    PubMed  CAS  Google Scholar 

  44. Carlan SJ, Gearity D, O'Brien WF. The effect of maternal blood contamination on the TDx-FLM II assay. Am J Perinatol 1997; 14: 491 - 494.

    PubMed  CAS  Google Scholar 

  45. Foerder CA, Tait JF, Franklin RW, Ashwood ER. Improved fluorescence polarization assay for use in evaluating fetal lung maturity: II. Analytical evaluation and comparison with the lecithin/sphingomyelin ratio. Clin Chem 1986; 32: 255 - 259.

    PubMed  CAS  Google Scholar 

  46. Cleary-Goldman J, Connolly T, Chelmow D, Malone F. Accuracy of the TDx-FLM assay of amniotic fluid: a comparison of vaginal pool samples with amniocentesis. J Matern Fetal Neonatal Med 2002; 11: 374 - 377.

    PubMed  CAS  Google Scholar 

  47. Russell JC, Cooper CM, Ketchum CH, et al. Multicenter evaluation of TDx test for assessing fetal lung maturity. Clin Chem 1989; 35: 1005 - 1010.

    PubMed  CAS  Google Scholar 

  48. Apple FS, Bilodeau L, Preese LM, Benson P. Clinical implementation of a rapid, automated assay for assessing fetal lung maturity. J Reprod Med 1994; 39: 883 - 887.

    PubMed  CAS  Google Scholar 

  49. Herbert WNP, Chapman JF, Schnoor MM. Role of the TDx FLM assay in fetal lung maturity. Am J Obstet Gynecol 1993; 168: 808 - 812.

    PubMed  CAS  Google Scholar 

  50. Steinfeld JD, Samuels P, Bulley MA, Cohen AW, Goodman DB, Senior MB. The utility of the TDx test in the assessment of fetal lung maturity. Obstet Gynecol 1992; 79: 460 - 464.

    PubMed  CAS  Google Scholar 

  51. McManamon TG, Mandsager N. Clinical outcome of neonates following the use of the FLM-II as the only test for fetal lung maturity [abstract]. Clin Chem 1998; 44: A157.

    Google Scholar 

  52. Moxness M, Lawson G, O'Brien J, Burritt M. Assessment of fetal lung maturity by the Abbott FLM II assay and three other methods [abstract]. Clin Chem 1995; 41: S95.

    Google Scholar 

  53. Dunston-Boone R, Chang T, Bernstein LH. Modified TDx assay for surfactant to albumin ratio in the assessment of fetal lung maturity [abstract]. Clin Chem 1997; 43: S196.

    Google Scholar 

  54. Fantz CR, Powell C, Karon B, et al. Assessment of the diagnostic accuracy of the TDx-FLM II to predict fetal lung maturity. Clin Chem 2002; 48: 761 - 765.

    PubMed  CAS  Google Scholar 

  55. Kesselman EJ, Figueroa R, Garry D, Maulik D. The usefulness of the TDx/TDxFLx fetal lung maturity II assay in the initial evaluation of fetal lung maturity. Am J Obstet Gynecol 2003; 188: 1220 - 1222.

    PubMed  Google Scholar 

  56. Ashwood ER, Tait JF, Foerder CA, Franklin RW, Benedetti TJ. Improved fluorescence polarization assay for use in evaluating fetal lung maturity: III. Retrospective clinical evaluation and comparison with the lecithin/sphingomyelin ratio. Clin Chem 1986; 32: 260 - 264.

    PubMed  CAS  Google Scholar 

  57. Tait JF, Foerder CA, Ashwood ER, Benedetti TJ. Prospective clinical evaluation of an improved fluorescence polarization assay for predicting fetal lung maturity. Clin Chem 1987; 33: 554 - 558.

    CAS  Google Scholar 

  58. Chen C, Roby PV, Weiss NS, Wilson JA, Benedetti TJ, Tait JF. Clinical evaluation of the NBD-PC fluorescence polarization assay for prediction of fetal lung maturity. Obstet Gynecol 1992; 80: 688 - 692.

    PubMed  CAS  Google Scholar 

  59. Ruch AT, Lenke RR, Ashwood ER. Assessment of fetal lung maturity by fluorescence polarization in high-risk pregnancies. J Reprod Med 1993; 38: 133 - 136.

    PubMed  CAS  Google Scholar 

  60. Tanasijevic MJ, Wybenga DR, Richardson D, Greene MF, Lopez R, Winkelman JW. A predictive model for fetal lung maturity employing gestational age and test results. Am J Clin Pathol 1994; 102: 788 - 793.

    PubMed  CAS  Google Scholar 

  61. Kaplan LA, Chapman JF, Bock JL, et al. Prediction of respiratory distress syndrome using the Abbott FLM-II amniotic fluid assay. Clin Chim Acta 2002; 326: 61 - 68.

    PubMed  CAS  Google Scholar 

  62. Pinette MG, Blackstone J, Wax JR, Cartin A. Fetal lung maturity indices: a plea for gestational age-specific interpretation: a case report and discussion. Am J Obstet Gynecol 2002; 187: 1721 - 1722.

    PubMed  Google Scholar 

  63. Tanasijevic M. Predictive model for fetal lung maturity assessment incorporating Abbott FLM S/A II test results and obstetric estimates of gestational age. Clin Chim Acta 2002; 326: 1 - 2.

    PubMed  CAS  Google Scholar 

  64. Stubblefield PG. Using the TDx-FLM assay and gestational age together for more accurate prediction of risk for neonatal respiratory distress syndrome. Am J Obstet Gynecol 2002; 187: 1429 - 1430.

    PubMed  Google Scholar 

  65. Gronowski AM, Parvin CA. Prediction of risk for respiratory distress syndrome using gestational age and the TDx FLM II assay. Am J Obstet Gynecol 2003; 189: 1511 - 1514.

    PubMed  Google Scholar 

  66. Friedman SA, Schiff E, Kao L, Kuint J, Sibai BM. Do twins mature earlier than singletons? Results from a matched cohort study. Am J Obstet Gynecol 1997; 176: 1193 - 1196.

    PubMed  CAS  Google Scholar 

  67. McElrath TF, Norwitz ER, Robinson JN, Tanasijevic MJ, Lieberman ES. Differences in TDx fetal lung maturity assay values between twin and singleton gestations. Am J Obstet Gynecol 2000; 182: 1110 - 1112.

    PubMed  CAS  Google Scholar 

  68. Whitworth NS, Magann EF, Morrison JC. Evaluation of fetal lung maturity in diamniotic twins. Am J Obstet Gynecol 1999; 180: 1438 - 1441.

    PubMed  CAS  Google Scholar 

  69. Del Valle GO, Adair CD, Ramos EE, Gaudier FL, Sanchez-Ramos L, Morales R. Interpretation of the TDx-FLM fluorescence polarization assay in pregnancies complicated by diabetes mellitus. Am J Perinatol 1997; 14: 241 - 244.

    PubMed  CAS  Google Scholar 

  70. Livingston EG, Herbert WN, Hage ML, Chapman JF, Stubbs TM for the Diabetes and Fetal Maturity Study Group. Use of the TDx-FLM assay in evaluating fetal lung maturity in an insulin-dependent diabetic population. Obstet Gynecol 1995; 86: 826 - 829.

    Google Scholar 

  71. Tanasijevic MJ, Winkelman JW, Wybenga DR, Richardson DK, Greene MF. Prediction of fetal lung maturity in infants of diabetic mothers using the FLM S/A and disaturated phosphatidylcholine tests. Am J Clin Pathol 1996; 105: 17 - 22.

    PubMed  CAS  Google Scholar 

  72. Gluck L, Kulovich MV, Borer RC Jr, Brenner PH, Anderson GG, Spellacy WN. Diagnosis of the respiratory distress syndrome by amniocentesis. Am J Obstet Gynecol 1971; 109: 440 - 445.

    PubMed  CAS  Google Scholar 

  73. Gluck L, Kulovich MV. Lecithin/sphingomyelin ratios in amniotic fluid in normal and abnormal pregnancy. Am J Obstet Gynecol 1973; 115: 539 - 546.

    PubMed  CAS  Google Scholar 

  74. Kulovich MV, Hallman MB, Gluck L. The lung profile: I. Normal pregnancy. Am J Obstet Gynecol 1979; 135: 57 - 63.

    PubMed  CAS  Google Scholar 

  75. Kulovich MV, Gluck L. The lung profile: II. Complicated pregnancy. Am J Obstet Gynecol 1979 135: 64 - 70.

    PubMed  CAS  Google Scholar 

  76. Ashwood ER. Standards of laboratory practice: evaluation of fetal lung maturity. Clin Chem 1997; 43: 1 - 4.

    Google Scholar 

  77. Touchstone JC, Levin SS, Dobbins MF, Beers PC. Analysis of saturated and unsaturated phospholipids in biological fluids. J Liquid Chromatogr 1983; 6: 179 - 192.

    CAS  Google Scholar 

  78. Torday J, Carson L, Lawson E. Saturated phosphatidylcholine in amniotic fluid and prediction of respiratory-distress syndrome. N Engl J Med 1979; 301: 1013 - 1018.

    PubMed  CAS  Google Scholar 

  79. Brown LM, Duck-Chong CG. Methods of evaluating fetal lung maturity. In: Batsakis J, Savory J, eds. Critical Reviews in Clinical Laboratory Science. Boca Raton, FL: CRC Press, 1982; pp. 84 - 159.

    Google Scholar 

  80. Penney LL, Hagerman DD, Sei CA. Specificity and reproducibility of acetone precipitation in identifying surface-active phosphatidylcholine in amniotic fluid. Clin Chem 1976; 22: 681 - 682.

    PubMed  CAS  Google Scholar 

  81. Hobson DW, Spillman T, Cotton DB. Effect of acetone precipitation on the clinical prediction of respiratory distress syndrome when utilizing amniotic fluid lecithin/sphingomyelin ratios. Am J Obstet Gynecol 1986; 154: 1023 - 1026.

    PubMed  CAS  Google Scholar 

  82. Dubin SB. Assessment of fetal lung maturity: practice parameter. Am J Clin Pathol 1998; 110: 723 - 732.

    PubMed  CAS  Google Scholar 

  83. Dombroski RA, Mackenna J, Brame RG. Comparison of amniotic fluid lung maturity profiles in paired vaginal and amniocentesis specimens. Am J Obstet Gynecol 1981; 140: 461 - 464.

    PubMed  CAS  Google Scholar 

  84. Shaver DC, Spinnato JA, Whybrew D, Williams WK, Anderson GD. Comparison of phospholipids in vaginal and amniocentesis specimens of patients with premature rupture of membranes. Am J Obstet Gynecol 1987; 156: 454 - 457.

    PubMed  CAS  Google Scholar 

  85. Gibbons JM, Huntley TE, Corral AG. Effect of maternal blood contamination on amniotic fluid analysis. Obstet Gynecol 1874; 44: 657 - 660.

    Google Scholar 

  86. Longo SA, Towers CV, Strauss A, Asrat T, Freeman RK. Meconium has no lecithin or sphingomyelin but affects the lecithin/sphingomyelin ratio. Am J Obstet Gynecol 1998; 179: 1640 - 1642.

    PubMed  CAS  Google Scholar 

  87. Lauria MR, Dombrowski MP, Delaney-Black V, Bottoms SF. Lung maturity tests: relation to source, clarity, gestational age and neonatal outcome. J Reprod Med 1996; 41: 685 - 591.

    PubMed  CAS  Google Scholar 

  88. Robert MF, Neff RK, Hubbell JP, Taeusch HW, Avery ME. Association between maternal diabetes and the respiratory-distress syndrome in the newborn. N Engl J Med 1976; 294: 357 - 360.

    PubMed  CAS  Google Scholar 

  89. Mimouni F, Miodovnik M, Whitsett JA, Holroyde JC, Siddiqi TA, Tsang RC. Respiratory distress syndrome in infants of diabetic mothers in the 1980s: no direct adverse effect of maternal diabetes with modern management. Obstet Gynecol 1987; 69: 191 - 195.

    PubMed  CAS  Google Scholar 

  90. Cruz AC, Buhi WC, Birk SA, Spellacy WN. Respiratory distress syndrome with mature lecithin/sphingomyelin ratios: diabetes mellitus and low Apgar scores. Am J Obstet Gynecol 1978; 126: 78 - 82.

    Google Scholar 

  91. Gabbe SG, Lowensohn RI, Mestman JH, Freeman RK, Goebelsmann U. Lecithin/sphingomyelin ratio in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol 1977; 128: 757 - 760.

    PubMed  CAS  Google Scholar 

  92. Tabsh KM, Brinkman CR 3rd, Bashore RA. Lecithin:sphingomyelin ratio in pregnancies complicated by insulin-dependent diabetes mellitus. Obstet Gynecol 1982; 59: 353 - 358.

    PubMed  CAS  Google Scholar 

  93. Piper JM, Langer O. Does maternal diabetes delay fetal pulmonary maturity? Am J Obstet Gynecol 1993; 168: 783 - 786.

    PubMed  CAS  Google Scholar 

  94. Berkowitz K, Reyes C, Saadat P, Kjos SL. Fetal lung maturation: comparison of biochemical indices in gestational diabetic and nondiabetic pregnancies. J Reprod Med 1997; 42: 793 - 800.

    PubMed  CAS  Google Scholar 

  95. Hallman M, Kulovich M, Kirkpatrick E, Sugarman RG, Gluck L. Phosphatidylinositol and phosphatidylglycerol in amniotic fluid: indices of lung maturity. Am J Obstet Gynecol 1976; 125: 613 - 617.

    PubMed  CAS  Google Scholar 

  96. Spillman T, Cotton DB. Current perspectives in assessment of fetal pulmonary surfactant status with amniotic fluid. Crit Rev Clin Lab Sci 1989; 27: 341 - 389.

    PubMed  CAS  Google Scholar 

  97. Bangham AD, Morely CJ, Phillips MC. The physical properties of an effective lung surfactant. Biochim Biophys Acta 1979; 573: 552 - 556.

    PubMed  CAS  Google Scholar 

  98. Jones GW, Ashwood ER. Enzymatic measurement of phosphatidylglycerol in amniotic fluid. Clin Chem 1994; 40: 518 - 525.

    PubMed  CAS  Google Scholar 

  99. Eisenbrey AB, Epstein E, Zak B, McEnroe RJ, Artiss JD, Kiechle FL. Phosphatidylglycerol in amniotic fluid: comparison of an "ultrasensitive" immunologic assay with TLC and enzymatic assay. Am J Clin Pathol 1989; 91: 293 - 297.

    PubMed  CAS  Google Scholar 

  100. Brame RG, MacKenna J. Vaginal pool phospholipids in the management of premature rupture of membranes. Am J Obstet Gynecol 1983; 145: 992 - 1000.

    PubMed  CAS  Google Scholar 

  101. Lewis DF, Towers CV, Major CA, et al. Use of Amniostat-FLM in detecting the presence of phosphatidylglycerol in vaginal pool samples in preterm premature rupture of membranes. Am J Obstet Gynecol 1993; 169: 573 - 576.

    PubMed  CAS  Google Scholar 

  102. Schumacher RE, Parisi VM, Steady HM, Tsao FHC. Bacteria causing false positive test for phosphatidylglycerol in amniotic fluid. Am J Obstet Gynecol 1985; 151: 1067 - 1068.

    PubMed  CAS  Google Scholar 

  103. Pastorek JG 2nd, Letellier RL, Gebbia K. Production of a phosphatidylglycerol-like substance by genital flora bacteria. Am J Obstet Gynecol 1988; 159: 199 - 202.

    PubMed  Google Scholar 

  104. Lambers DS, Brady K, Leist PA, Setser C, Heimchen R. Ability of normal vaginal flora to produce detectable phosphatidylglycerol in amniotic fluid in vitro. Obstet Gynecol 1995; 85: 651 - 655.

    PubMed  CAS  Google Scholar 

  105. Farquharson J, Jamieson EC, Berry E, Buchanan R, Logan RW. Assessment of the AmnioStat-FLM immunoagglutination test for phosphatidylglycerol in amniotic fluid. Clin Chim Acta 1986; 156: 27 1277.

    Google Scholar 

  106. Benoit J, Merrill S, Rundell C, Meeker CI. Amniostat-FLM: an initial clinical trial with both vaginal pool and amniocentesis samples. Am J Obstet Gynecol 1986; 154: 65 - 68.

    PubMed  CAS  Google Scholar 

  107. Halvorsen PR, Gross TL. Laboratory and clinical evaluation of a rapid slide agglutination test for phosphatidylglycerol. Am J Obstet Gynecol 1985; 151: 1061 - 1066.

    PubMed  CAS  Google Scholar 

  108. Weinbaum PJ, Richardson D, Schwartz JS, Gabbe SG. Amniostat FLM: a new technique for detection of phosphatidylglycerol in amniotic fluid. Am J Perinatol 1985; 2: 88 - 92.

    PubMed  CAS  Google Scholar 

  109. Lockitch G, Wittmann BK, Mura SM, Hawkley LC. Evaluation of the Amniostat-FLM assay for assessment of fetal lung maturity. Clin Chem 1984; 30: 1233 - 1237.

    PubMed  CAS  Google Scholar 

  110. Garite TJ, Yabusaki KK, Moberg LJ, et al. A new rapid slide agglutination test for amniotic fluid phosphatidylglycerol: laboratory and clinical correlation. Am J Obstet Gynecol 1983; 147: 681 - 686.

    PubMed  CAS  Google Scholar 

  111. Towers CV, Garite TJ. Uselessness of the phosphatidylglycerol assay for prediction of lung maturity [reply]. Am J Obstet Gynecol 1989; 161: 1419.

    Google Scholar 

  112. Spillman TA, Cotton DB, Golunski E. Detection frequency by thin-layer chromatography of phosphatidylglycerol in amniotic fluid with clinically functional pulmonary surfactant. Clin Chem 1988; 34: 1976 - 1982.

    PubMed  CAS  Google Scholar 

  113. Tsai MY, Shultz EK, Nelson JA. Amniotic fluid phosphatidylglycerol in diabetic and control pregnant patients at different gestational lengths. Am J Obstet Gynecol 1984; 149: 388 - 392.

    PubMed  CAS  Google Scholar 

  114. Cunningham MD, McKean HE, Gillispie DH, Greene JW. Improved prediction of fetal lung maturity in diabetic pregnancies: a comparison of chromatographic methods. Am J Obstet Gynecol 1982; 142: 197 - 204.

    PubMed  CAS  Google Scholar 

  115. Piper JM, Xenakis EM, Langer O. Delayed appearance of pulmonary maturation markers is associated with poor glucose control in diabetic pregnancies. J Matern Fetal Med 1998; 7: 148 - 153.

    PubMed  CAS  Google Scholar 

  116. Saad SA, Fadel HE, Fahmy K, Nelson GH, Moustafa M, Davis HC. The reliability and clinical use of a rapid phosphatidylglycerol assay in normal and diabetic pregnancies. Am J Obstet Gynecol 1987; 157: 1516 - 1520.

    PubMed  CAS  Google Scholar 

  117. Ashwood ER, Oldroyd RG, Palmer SE. Measuring the number of lamellar body particles in amniotic fluid. Obstet Gynecol 1990; 75: 289 - 292.

    PubMed  CAS  Google Scholar 

  118. Dubin SB. Characterization of amniotic fluid lamellar bodies by resistive-pulse counting: relationship to measures of fetal lung maturity. Clin Chem 1989; 35: 612 - 616.

    PubMed  CAS  Google Scholar 

  119. Ashwood ER, Palmer SE, Taylor JS, Pingree SS. Lamellar body counts for rapid fetal lung maturity testing. Obstet Gynecol 1993; 81: 619 - 624.

    PubMed  CAS  Google Scholar 

  120. Neerhof MG, Dohnal JC, Ashwood ER, Lee IS, Anceschi MM. Lamellar body counts: a consensus on protocol. Obstet Gynecol 2001; 97: 318 - 320.

    PubMed  CAS  Google Scholar 

  121. Szallasi A, Gronowski AM, Eby CS. Lamellar body count in amniotic fluid: a comparative study of four different hematology analyzers. Clin Chem 2003; 49: 994 - 997.

    PubMed  CAS  Google Scholar 

  122. Greenspoon JS, Rosen DJ, Roll K, Dubin SB. Evaluation of lamellar body number density as the initial assessment in a fetal lung maturity test cascade. J Reprod Med 1995; 40: 260 - 266.

    PubMed  CAS  Google Scholar 

  123. Bowie LJ, Shammo J, Dohnal JC, Farrell E, Vye MV. Lamellar body number density and the prediction of respiratory distress. Am J Clin Pathol 1991; 95: 781 - 786.

    PubMed  CAS  Google Scholar 

  124. Dalence CR, Bowie LJ, Dohnal JC, Farrell EE, Neerhof MG. Amniotic fluid lamellar body count: a rapid and reliable fetal lung maturity test. Obstet Gynecol 1995; 86: 235 - 239.

    PubMed  CAS  Google Scholar 

  125. Fakhoury G, Daikoku NH, Benser J, Dubin NH. Lamellar body concentrations and the prediction of fetal pulmonary maturity. Am J Obstet Gynecol 1994; 170: 72 - 76.

    PubMed  CAS  Google Scholar 

  126. Lee IS, Cho YK, Kim A, Min WK, Kim KS, Mok JE. Lamellar body count in amniotic fluid as a rapid screening test for fetal lung maturity. J Perinatol 1996; 16: 176 - 180.

    PubMed  CAS  Google Scholar 

  127. Pearlman ES, Baiocchi JM, Lease JA, Gilbert J, Cooper JH. Utility of a rapid lamellar body count in the assessment of fetal maturity. Am J Clin Pathol 1991; 95: 778 - 780.

    PubMed  CAS  Google Scholar 

  128. Dilena BA, Ku F, Doyle I, Whiting MJ. Six alternative methods to the lecithin/sphingomyelin ratio in amniotic fluid for assessing fetal lung maturity. Ann Clin Biochem 1997; 34: 106 - 108.

    PubMed  CAS  Google Scholar 

  129. Neerhof MG, Haney EI, Silver RK, Ashwood ER, Lee IS, Piazze JJ. Lamellar body counts compared with traditional phospholipid analysis as an assay for evaluating fetal lung maturity. Obstet Gynecol 2001; 97: 305 - 309.

    PubMed  CAS  Google Scholar 

  130. Beinlich A, Fischass C, Kaufmann M, Schlosser R, Dericks-Tan JS. Lamellar body counts in amniotic fluid for prediction of fetal lung maturity. Arch Gynecol Obstet 1999; 262: 173 - 180.

    PubMed  CAS  Google Scholar 

  131. Wijnberger LD, Huisjes AJ, Voorbij HA, Franx A, Bruinse HW, Mol BW. The accuracy of lamellar body count and lecithin/sphingomyelin ratio in the prediction of neonatal respiratory distress syndrome: a meta-analysis. Br J Obstet Gynecol 2001; 108: 583 - 588.

    CAS  Google Scholar 

  132. DeRoche ME, Ingardia CJ, Guerette PJ, Wu AH, LaSala CA, Mandavilli SR. The use of lamellar body counts to predict fetal lung maturity in pregnancies complicated by diabetes mellitus. Am J Obstet Gynecol 2002; 187: 908 - 912.

    PubMed  Google Scholar 

  133. Clements JA, Platzker AC, Tierney DF, et al. Assessment of the risk of the respiratory-distress syndrome by a rapid test for surfactant in amniotic fluid. N Engl J Med 1972; 286: 1077 - 1081.

    PubMed  CAS  Google Scholar 

  134. Sher G, Statland BE, Freer DE, Kraybill EN. Assessing fetal lung maturation by the foam stability index test. Obstet Gynecol 1978; 52: 673 - 677.

    PubMed  CAS  Google Scholar 

  135. Keniston RC, Noland GL, Pernoll ML. The effect of blood, meconium, and temperature on the rapid surfactant test. Obstet Gynecol 1976; 48: 442 - 446.

    PubMed  CAS  Google Scholar 

  136. Sher G, Statland BE, Freer DE. Clinical evaluation of the quantitative foam stability index test. Obstet Gynecol 1980; 55: 617 - 620.

    PubMed  CAS  Google Scholar 

  137. Sher G, Statland BE, Knutzen VK. Diagnostic reliability of the lecithin/sphingomyelin ratio assay and the quantitative foam stability index test: results of a comparative study. J Reprod Med 1982; 27: 51 - 55.

    PubMed  CAS  Google Scholar 

  138. Sher G, Statland BE. Assessment of fetal pulmonary maturity by the Lumadex foam stability index test. Obstet Gynecol 1983; 61: 444 - 449.

    PubMed  CAS  Google Scholar 

  139. Lockitch G, Wittmann BK, Snow BE, Campbell DJ. Prediction of fetal lung maturity by use of the Lumadex-FSI test. Clin Chem 1986; 32: 361 - 363.

    PubMed  CAS  Google Scholar 

  140. Lipshitz J, Whybrew WD, Anderson GD. Comparison of the Lumadex-foam stability index test, lecithin: sphingomyelin ratio, and simple shake test for fetal lung maturity. Obstet Gynecol 1984; 63: 349 - 354.

    PubMed  CAS  Google Scholar 

  141. Garite TJ, Freeman RK, Nageotte MP. Fetal maturity cascade: a rapid and cost-effective method for fetal lung maturity testing. Obstet Gynecol 1986; 67: 619 - 622.

    PubMed  CAS  Google Scholar 

  142. Wong SS, Schenkel O, Qutishat A. Strategic utilization of fetal lung maturity tests. Scand J Clin Lab Invest 1996; 56: 525 - 532.

    PubMed  CAS  Google Scholar 

  143. Bonebrake RG, Towers CV, Rumney PJ, Reimbold P. Is fluorescence polarization reliable and cost efficient in a fetal lung maturity cascade? Am J Obstet Gynecol 1997; 177: 835 - 841.

    PubMed  CAS  Google Scholar 

  144. Lewis PS, Lauria MR, Dzieczkowski J, Utter GO, Dombrowski MP. Amniotic fluid lamellar body count: cost-effective screening for fetal lung maturity. Obstet Gynecol 1999; 93: 387 - 391.

    PubMed  CAS  Google Scholar 

  145. Ross GE, Bever FN, Uddin Z, Hockman EM, Herman BA. Decreased laboratory testing for lecithinto-sphingomyelin ratio and phosphatidylglycerol after fetal lung maturity assessment from lamellar body count in amniotic fluid. J Am Osteopath Assoc 2002; 102: 423 - 428.

    PubMed  Google Scholar 

Download references

Authors
  1. Edward R. Ashwood MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Departments of Pathology and Immunology and Obstetrics and Gynecology, Washington University School of Medicine, and Clinical Chemistry and Serology Laboratories, Barnes-Jewish Hospital, St. Louis, MO, USA

    Ann M. Gronowski PhD, DABCC

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Humana Press, Totowa, NJ

About this chapter

Cite this chapter

Ashwood, E.R. (2004). Markers of Fetal Lung Maturity. In: Gronowski, A.M. (eds) Handbook of Clinical Laboratory Testing During Pregnancy. Current Clinical Pathology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-787-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-787-1_4

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9862-2

  • Online ISBN: 978-1-59259-787-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation